» Articles » PMID: 3012531

Chromatin Binding of Epidermal Growth Factor, Nerve Growth Factor, and Platelet-derived Growth Factor in Cells Bearing the Appropriate Surface Receptors

Overview
Specialty Science
Date 1986 Jun 1
PMID 3012531
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

We analyzed the uptake and intracellular distribution of 125I-labeled epidermal growth factor, nerve growth factor, and platelet-derived growth factor in different cell lines that express or do not express the respective surface receptors for these factors. After 1 hr of incubation, all three growth factors were detected in the cytoplasmic fraction and in the nucleus, tightly bound to chromatin. The amount of chromatin-bound growth factors continued to increase during the incubation, and analysis at 48 hr revealed each chromatin-bound labeled growth factor in a nondegraded form. After limited digestion of chromatin with DNase II (10-20% digested sequences), specific release of all three growth factors was detected only after 1 hr of incubation but not after 24 and 48 hr, suggesting that the DNA regions involved in growth factor binding became nuclease-resistant. Binding of labeled epidermal growth factor and nerve growth factor to isolated chromatin was inhibited by monoclonal antibodies specific for the respective growth factor receptor. The data suggest that chromatin binding may represent an important step in the pathway of growth factor action.

Citing Articles

The growth hormone receptor interacts with transcriptional regulator HMGN1 upon GH-induced nuclear translocation.

Jain L, Vickers M, Jacob B, Middleditch M, Chudakova D, Ganley A J Cell Commun Signal. 2023; 17(3):925-937.

PMID: 37043098 PMC: 10409943. DOI: 10.1007/s12079-023-00741-2.


The NAE Pathway: Autobahn to the Nucleus for Cell Surface Receptors.

Shah P, Chaumet A, Royle S, Bard F Cells. 2019; 8(8).

PMID: 31426451 PMC: 6721735. DOI: 10.3390/cells8080915.


An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRα Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma.

Yoon S, Wu X, Armstrong B, Habib N, Rossi J Mol Ther Nucleic Acids. 2018; 14:131-141.

PMID: 30594071 PMC: 6307106. DOI: 10.1016/j.omtn.2018.11.012.


RETRACTED: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor.

Brand T, Iida M, Corrigan K, Braverman C, Coan J, Flanigan B Sci Signal. 2017; 10(460).

PMID: 28049763 PMC: 7094775. DOI: 10.1126/scisignal.aag1064.


IGFBP2 potentiates nuclear EGFR-STAT3 signaling.

Chua C, Liu Y, Granberg K, Hu L, Haapasalo H, Annala M Oncogene. 2015; 35(6):738-47.

PMID: 25893308 PMC: 4615268. DOI: 10.1038/onc.2015.131.


References
1.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

2.
Vanderbilt J, Anderson J . Monoclonal antibodies to tissue-specific chromatin proteins. J Biol Chem. 1983; 258(12):7751-6. View

3.
Gottesfeld J, Bagi G, Berg B, Bonner J . Sequence composition of the template-active fraction of rat liver chromatin. Biochemistry. 1976; 15(11):2472-83. DOI: 10.1021/bi00656a034. View

4.
Carpenter G, Cohen S . 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J Cell Biol. 1976; 71(1):159-71. PMC: 2109737. DOI: 10.1083/jcb.71.1.159. View

5.
Fabricant R, De Larco J, Todaro G . Nerve growth factor receptors on human melanoma cells in culture. Proc Natl Acad Sci U S A. 1977; 74(2):565-9. PMC: 392331. DOI: 10.1073/pnas.74.2.565. View